Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-14 to 2025-03-17
Current total value of award: $58.07
Description: 4567584029!CLONAZEPAM 0.5 MG TABLET 100S